Target intelligence / Profile preview

RNA, U4atac small nuclear 3, pseudogene (RNU4ATAC3P)

Target
RNU4ATAC3P
Molecular classification
Pseudogene, Small nuclear RNA (snRNA) pseudogene
01

Overview

RNA, U4atac small nuclear 3, pseudogene (RNU4ATAC3P) is a non-functional genomic sequence classified as a pseudogene. It shares homology with the RNU4ATAC gene, which encodes the U4atac small nuclear RNA, an essential component of the minor spliceosome. Unlike its parent gene, RNU4ATAC3P does not produce a functional RNA product and is not involved in normal or disease pathogenesis. Pseudogenes such as RNU4ATAC3P typically arise from duplication or retrotransposition events and may occasionally play regulatory roles at the RNA level, but no such function has been described for this locus[1][5]. The RNU4ATAC3P gene is annotated as a *pseudogene* in major databases, indicating it does not encode a functional RNA[1]. The functional RNU4ATAC gene, not the pseudogene, is critical for minor intron splicing and is associated with developmental disorders when mutated[6][7]. Pseudogenes in general might affect gene expression (e.g., via competing endogenous RNA or small interfering RNAs) in some cases[5], but there is no evidence that RNU4ATAC3P has such a functional role. No drugs, disease biomarkers, or safety concerns are associated with this sequence[1][5]. It is not considered a receptor, enzyme, transporter, transcription factor, or therapeutic target by any biomedical resource. If you need information about the functional gene **RNU4ATAC** instead, it is distinct and has known disease associations and biological functions relevant to splicing disorders[2][4][6][7].

Other names
RNU4ATAC3PRNA, U4atac small nuclear 3, pseudogene
02

Mechanism of action

None known (No approved or experimental drugs are known to target this pseudogene.)

03

Biological functions

None known for this specific pseudogene (General pseudogenes may contribute to regulation of parental gene expression via RNA interference pathways, but there is no evidence this pseudogene has an established function[5]).
04

Disease associations

None established for this pseudogene (Functional RNU4ATAC gene mutations, not pseudogenes, are associated with developmental diseases[6][7]).
05

Safety considerations

None known (Pseudogenes do not produce proteins and are not considered therapeutic targets or biomarkers.)
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on RNA, U4atac small nuclear 3, pseudogene (RNU4ATAC3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4atac small nuclear 3, pseudogene (RNU4ATAC3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call